Provided by Tiger Fintech (Singapore) Pte. Ltd.

Menlo Therapeutics Inc.

1.35
+0.0000
Volume:- -
Turnover:- -
Market Cap:226.29M
PE:-0.67
High:1.35
Open:1.35
Low:1.35
Close:1.35
Loading ...
Aug 20, 2019

Major Issues Report

Current report, item 5.02
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 27, 2019

Major Issues Report

Current report, item 5.07
Jun 06, 2019

Major Issues Report

Current report, item 5.02
May 02, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Feb 11, 2019

Correspondence

[Cover]Correspondence